DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

Late-onset epilepsy (LOE) may represent a distinctive neurodegenerative-linked epilepsy subtype, with new data showing that individuals who develop epilepsy after midlife have substantially greater ...

Lisa Smith’s 14-year-old daughter, Haley, had run out of options. She was having roughly two dozen seizures a day and had tried “17 or 18” different pharmaceutical regimens, different diets, and an ...

The unpredictable, debilitating nature of a seizure can be frightening, for both the person experiencing it and any loved ones watching nearby. In that moment, control often slips away as muscles ...

For the first time, clinicians have access to a clear, evidence-based roadmap for adjusting antiseizure medication doses during pregnancy and after childbirth. The strategies, practiced by a group of ...

A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy (DRE) who were not referred for surgical evaluation and flagged those overdue ...

Identifying childhood epilepsy at an early stage is vital; a late diagnosis can hinder a child's growth and education.

Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a new study says. More than half of TikTok videos regarding epilepsy featured ...

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness ...